These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4324041)

  • 1. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibiotic resistance of Mycobacterium. Standard test method and its clinical use in Japan].
    Ushiba D
    Torax; 1966 Mar; 15(1):14-24. PubMed ID: 4957544
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug.
    Toyohara M; Nagata A; Hayano K; Abe J
    Am Rev Respir Dis; 1969 Aug; 100(2):228-30. PubMed ID: 4308717
    [No Abstract]   [Full Text] [Related]  

  • 4. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. Capreomycin and other drugs in the treatment of pulmonary tuberculosis.
    Zierski M
    Tubercle; 1969 Mar; 50():Suppl:37-9. PubMed ID: 4319132
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B; Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study on tuberactinomycin-N, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1972 Jun; 47(6):177-80. PubMed ID: 5081206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiograms in therapeutic management of pulmonary tuberculosis].
    Cărare A; Păun M; Armaşu C; Tănase C
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(2):506-9. PubMed ID: 4979402
    [No Abstract]   [Full Text] [Related]  

  • 10. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of new antitubercular agents--new quinolones].
    Kawahara S; Eirei J
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1453572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 20. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.